Found 3809 matching trials
Human Upper Extremity Allotransplantation
PHASE2Background: Millions of people each year sustain injuries, have tumors surg...
Location
Johns Hopkins University School of Medicine
Clinical Study of Microdosing Carboplatin in Lung or Bladder Cancer
EARLY_PHASE1Carboplatin kills cancer cells mainly through induction of DNA damage (drug...
Location
University of California Los Angeles
Human Pharmacology Study (Keppra Dry Syrup Bioequivalence Study)
PHASE1To demonstrate the bioequivalence of a Levetiracetam dry syrup (50% (500mg/...
Location
Multiple Locations
A Phase 1 Study of PROT-001.
PHASE1A Phase 1, First-In-Human, Randomized, Double-Blind, Placebo-Controlled Mul...
Location
Nucleus Network Pty Ltd
Part B- G1X-CGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease
PHASE1Background:
X-Linked Chronic Granulomatous Disease (X-CGD) is caused by a ...
Status
Enrolling By Invitation
Location
National Institutes of Health Clinical Center
Training Local Leaders to Prevent and Reduce Domestic Violence Evidence From Peru
NALeaders in Action (LIA) is a norms-centered intervention that aims to reduc...
Location
Innovations for Poverty Action
Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU II)
PHASE3It is hypothesized that application at 4-week or greater intervals of the h...
Location
LakeView Clinical Research
Safety Evaluation of Intranasal Use of DSM 32444 Postbiotic in Humans
NARhinitis is a type of upper respiratory infection with a common nasal patho...
Location
Thai Binh University of Medicine and Pharmacy
Safety and Tolerability Study of CTx1000 In Participants With Amyotrophic Lateral Sclerosis
PHASE1This clinical study is in participants with Amyotrophic Lateral Sclerosis a...
Location
Macquarie University Hospital
NBE-002 in Patients With Advanced Solid Tumors
PHASE1This first-in-human study will evaluate the recommended dose for further cl...
Location
Sarah Cannon Research Institute - TN Oncology